Key result
Bilateral pulmonary endarterectomy and tricuspid valve replacement were performed in a 42-year-old patient with calcified amorphous tumour-related pulmonary hypertension.
Case Report (n=1)
Yes
Pulmonary endarterectomy combined with tricuspid valve replacement is a feasible surgical approach for treating calcified amorphous tumour-related pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
Single case supports surgical feasibility in calcified amorphous tumour-related PH; leaves open efficacy, safety, and generalizability.
A 42-year-old patient presenting with exertional dyspnoea was diagnosed with functional class II pulmonary hypertension (PH) with severe tricuspid valve insufficiency due to cardiac and pulmonary artery obstruction by calcified amorphous tumour (paCAT). Bilateral (sub)segmental perfusion defects were seen on ventilation/perfusion scan (see online supplementary figure S1), while the CT angiogram showed large amounts of calcified radio-opaque material in absence of radiological characteristics of chronic thromboembolic pulmonary hypertension (CTEPH), such as webs, stenosis or pouches (figure 1A, C). After multi-institutional (Amsterdam, NL and Papworth, Cambridge, UK) assessment of the case, a decision was made to perform a complete, bilateral, pulmonary endarterectomy (PEA) combined with tricuspid valve replacement. During PEA bone-hard material was retrieved that lacked the (sub)segmental pulmonary …
No takes yet. Share an insight, caveat, or question.
Bonta et al. (2016) conducted a case report in calcified amorphous tumour-related pulmonary hypertension (n=1). Bilateral pulmonary endarterectomy combined with tricuspid valve replacement was evaluated. Bilateral pulmonary endarterectomy and tricuspid valve replacement were performed in a 42-year-old patient with calcified amorphous tumour-related pulmonary hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: